Zoledronic acid and Lantus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zoledronic acid (zoledronic acid) and Lantus (insulin glargine recombinant). Common drug interactions include diarrhoea among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Zoledronic acid and Lantus. It is created by eHealthMe based on reports of 133 people who take the same drugs from the FDA, and is updated regularly.
What is Zoledronic acid?
Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
133 people who take Zoledronic acid and Lantus together, and have interactions are studied.
What are the common drug interactions of Zoledronic acid and Lantus, by gender? *
What are the common drug interactions of Zoledronic acid and Lantus, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zoledronic acid and Lantus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Zoledronic acid (28,485 reports)
- Lantus (191,782 reports)
Browse all drug interactions of Zoledronic acid and Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zoledronic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoledronic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid and insulin glargine recombinant (the active ingredients of Zoledronic acid and Lantus, respectively), and Zoledronic acid and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Livalo and Blood Glucose Increased for Men aged 60+ - 7 seconds ago
- Drug interactions of Trazodone Hydrochloride and Augmentin '125' - 8 seconds ago
- Cardizem Sr vs. Lotrel, side effect and effectiveness comparison - 14 seconds ago
- Drug interactions of Androderm and Cozaar - 19 seconds ago
- Seroquel and Naprosyn drug interactions for men aged 40-49 - 31 seconds ago
- Could Codeine cause Trigger Finger? - 31 seconds ago
- Drug interactions of Vitamin C and Leucovorin Calcium - 36 seconds ago
- Could Belviq cause Weight Increased? - 39 seconds ago
- Victoza and Pancreatitis Aggravated for Women aged 50-59 - 56 seconds ago
- Xenical and Sleep Disorder for Women aged 40-49 - 58 seconds ago